USPH Operating Income from 2010 to 2026

USPH Stock

USD 82.64 0.52 0.63%

US Physicalrapy's Operating Income is increasing with slightly volatile movements from year to year. Operating Income is estimated to finish at about 76.3 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit US Physicalrapy generates from its operations. View All Fundamentals

Operating Income

First Reported

1991-03-31

Previous Quarter

24.9 M

Current Value

25.3 M

Quarterly Volatility

6.4 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.7 M, Total Revenue of 810.6 M or Gross Profit of 149.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0195 or PTB Ratio of 4.65. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.

Build AI portfolio with USPH Stock

Check out the analysis of US Physicalrapy Correlation against competitors.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

The Operating Income trend for US Physicalrapy offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether US Physicalrapy is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest US Physicalrapy's Operating Income Growth Pattern

Below is the plot of the Operating Income of US Physicalrapy over the last few years. Operating Income is the amount of profit realized from US Physicalrapy operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of US Physicalrapy is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. US Physicalrapy's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

USPH Operating Income Regression Statistics

	Arithmetic Mean	51,848,685
	Coefficient Of Variation	35.00
	Mean Deviation	12,722,564
	Median	52,413,000
	Standard Deviation	18,145,630
	Sample Variance	329.3T
	Range	76.6M
	R-Value	0.83
	Mean Square Error	107.2T
	R-Squared	0.69
	Significance	0.000032
	Slope	2,994,986
	Total Sum of Squares	5268.2T

USPH Operating Income History

	2026	76.3 M
	2025	72.7 M
	2024	63.2 M
	2023	52.1 M
	2022	56.8 M
	2021	70.6 M
	2020	52.4 M

Other Fundumenentals of US Physicalrapy

Non Operating Income Net Other

US Physicalrapy Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.93	0.91	0.9	0.95	0.99	0.88	0.96	0.98	-0.35	0.63	0.91	-0.28	0.93	0.03	0.1	-0.86	0.71	0.91	0.8	0.61	-0.83	0.92	0.87	0.07	0.83
Total Stockholder Equity	0.99		0.87	0.9	0.85	0.93	0.96	0.92	0.94	0.97	-0.4	0.68	0.88	-0.33	0.9	0.06	0.03	-0.83	0.7	0.88	0.78	0.58	-0.8	0.92	0.86	0.15	0.85
Net Debt	0.93	0.87		0.83	0.96	0.91	0.96	0.69	0.94	0.93	-0.25	0.5	0.93	-0.18	0.93	-0.03	0.16	-0.86	0.62	0.91	0.74	0.53	-0.76	0.85	0.81	-0.16	0.72
Retained Earnings	0.91	0.9	0.83		0.83	0.93	0.89	0.83	0.85	0.84	-0.65	0.81	0.81	-0.6	0.8	0.27	-0.18	-0.74	0.76	0.8	0.84	0.66	-0.89	0.75	0.7	-0.03	0.62
Accounts Payable	0.9	0.85	0.96	0.83		0.89	0.94	0.71	0.87	0.89	-0.35	0.56	0.95	-0.28	0.96	0.05	0.05	-0.9	0.59	0.95	0.71	0.5	-0.75	0.78	0.81	-0.05	0.68
Net Receivables	0.95	0.93	0.91	0.93	0.89		0.92	0.75	0.88	0.94	-0.51	0.72	0.85	-0.44	0.83	0.13	-0.09	-0.74	0.73	0.84	0.76	0.6	-0.79	0.85	0.74	-0.14	0.74
Total Liab	0.99	0.96	0.96	0.89	0.94	0.92		0.85	0.98	0.97	-0.31	0.58	0.95	-0.24	0.97	0.01	0.14	-0.91	0.68	0.94	0.8	0.59	-0.83	0.9	0.88	0.05	0.8
Total Current Assets	0.88	0.92	0.69	0.83	0.71	0.75	0.85		0.83	0.81	-0.41	0.67	0.82	-0.36	0.83	0.13	-0.01	-0.81	0.64	0.81	0.75	0.57	-0.79	0.79	0.83	0.48	0.76
Short Term Debt	0.96	0.94	0.94	0.85	0.87	0.88	0.98	0.83		0.93	-0.23	0.52	0.87	-0.17	0.91	-0.03	0.24	-0.84	0.65	0.85	0.8	0.59	-0.82	0.89	0.86	0.01	0.79
Intangible Assets	0.98	0.97	0.93	0.84	0.89	0.94	0.97	0.81	0.93		-0.27	0.57	0.9	-0.19	0.92	-0.04	0.12	-0.84	0.64	0.9	0.72	0.53	-0.74	0.95	0.86	0.01	0.86
Good Will	-0.35	-0.4	-0.25	-0.65	-0.35	-0.51	-0.31	-0.41	-0.23	-0.27		-0.89	-0.29	0.99	-0.23	-0.64	0.82	0.22	-0.38	-0.26	-0.34	-0.26	0.39	-0.19	-0.17	0.02	-0.14
Common Stock	0.63	0.68	0.5	0.81	0.56	0.72	0.58	0.67	0.52	0.57	-0.89		0.54	-0.85	0.5	0.7	-0.61	-0.49	0.54	0.52	0.62	0.49	-0.58	0.49	0.56	0.06	0.53
Long Term Debt	0.91	0.88	0.93	0.81	0.95	0.85	0.95	0.82	0.87	0.9	-0.29	0.54		-0.24	0.97	0.02	0.08	-0.96	0.61	0.98	0.72	0.52	-0.77	0.84	0.87	0.17	0.73
Treasury Stock	-0.28	-0.33	-0.18	-0.6	-0.28	-0.44	-0.24	-0.36	-0.17	-0.19	0.99	-0.85	-0.24		-0.16	-0.64	0.83	0.17	-0.35	-0.2	-0.3	-0.23	0.37	-0.11	-0.11	0.01	-0.04
Property Plant Equipment	0.93	0.9	0.93	0.8	0.96	0.83	0.97	0.83	0.91	0.92	-0.23	0.5	0.97	-0.16		-0.03	0.17	-0.97	0.58	0.97	0.73	0.51	-0.77	0.85	0.9	0.16	0.77
Current Deferred Revenue	0.03	0.06	-0.03	0.27	0.05	0.13	0.01	0.13	-0.03	-0.04	-0.64	0.7	0.02	-0.64	-0.03		-0.57	-0.04	0.14	-0.01	0.35	0.33	-0.16	-0.09	0.2	-0.06	0.12
Short Term Investments	0.1	0.03	0.16	-0.18	0.05	-0.09	0.14	-0.01	0.24	0.12	0.82	-0.61	0.08	0.83	0.17	-0.57		-0.13	0.04	0.1	0.17	0.18	-0.14	0.14	0.18	-0.03	0.13
Net Tangible Assets	-0.86	-0.83	-0.86	-0.74	-0.9	-0.74	-0.91	-0.81	-0.84	-0.84	0.22	-0.49	-0.96	0.17	-0.97	-0.04	-0.13		-0.54	-0.95	-0.7	-0.47	0.74	-0.79	-0.9	-0.24	-0.71
Total Permanent Equity	0.71	0.7	0.62	0.76	0.59	0.73	0.68	0.64	0.65	0.64	-0.38	0.54	0.61	-0.35	0.58	0.14	0.04	-0.54		0.6	0.81	0.78	-0.78	0.57	0.5	-0.04	0.44
Long Term Debt Total	0.91	0.88	0.91	0.8	0.95	0.84	0.94	0.81	0.85	0.9	-0.26	0.52	0.98	-0.2	0.97	-0.01	0.1	-0.95	0.6		0.71	0.49	-0.76	0.8	0.86	0.19	0.74
Capital Surpluse	0.8	0.78	0.74	0.84	0.71	0.76	0.8	0.75	0.8	0.72	-0.34	0.62	0.72	-0.3	0.73	0.35	0.17	-0.7	0.81	0.71		0.88	-0.93	0.64	0.75	-0.04	0.59
Deferred Long Term Liab	0.61	0.58	0.53	0.66	0.5	0.6	0.59	0.57	0.59	0.53	-0.26	0.49	0.52	-0.23	0.51	0.33	0.18	-0.47	0.78	0.49	0.88		-0.77	0.46	0.54	-0.07	0.42
Accumulated Depreciation	-0.83	-0.8	-0.76	-0.89	-0.75	-0.79	-0.83	-0.79	-0.82	-0.74	0.39	-0.58	-0.77	0.37	-0.77	-0.16	-0.14	0.74	-0.78	-0.76	-0.93	-0.77		-0.64	-0.67	-0.01	-0.48
Short Long Term Debt	0.92	0.92	0.85	0.75	0.78	0.85	0.9	0.79	0.89	0.95	-0.19	0.49	0.84	-0.11	0.85	-0.09	0.14	-0.79	0.57	0.8	0.64	0.46	-0.64		0.84	0.09	0.86
Net Invested Capital	0.87	0.86	0.81	0.7	0.81	0.74	0.88	0.83	0.86	0.86	-0.17	0.56	0.87	-0.11	0.9	0.2	0.18	-0.9	0.5	0.86	0.75	0.54	-0.67	0.84		0.23	0.9
Net Working Capital	0.07	0.15	-0.16	-0.03	-0.05	-0.14	0.05	0.48	0.01	0.01	0.02	0.06	0.17	0.01	0.16	-0.06	-0.03	-0.24	-0.04	0.19	-0.04	-0.07	-0.01	0.09	0.23		0.2
Capital Stock	0.83	0.85	0.72	0.62	0.68	0.74	0.8	0.76	0.79	0.86	-0.14	0.53	0.73	-0.04	0.77	0.12	0.13	-0.71	0.44	0.74	0.59	0.42	-0.48	0.86	0.9	0.2

Click cells to compare fundamentals

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's Operating Income, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Operating Income	72.7 M	76.3 M
Non Operating Income Net Other	2.9 M	2.3 M

Currently Active Assets on Macroaxis

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill
CSAN	Cosan SA ADR
RKT	Rocket Companies

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of US Physicalrapy Correlation against competitors.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.236

Dividend Share

1.79

Earnings Share

2.37

Revenue Per Share

49.547

Quarterly Revenue Growth

0.173

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

USPH Operating Income from 2010 to 2026

Latest US Physicalrapy's Operating Income Growth Pattern

USPH Operating Income Regression Statistics

USPH Operating Income History

Other Fundumenentals of US Physicalrapy

US Physicalrapy Operating Income component correlations

About US Physicalrapy Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY